RxDoctor Payments Data

David Harpole, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Durham, NCNPI 1386734564

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $112,197 of the $177,348 with a category attached, or 63.3%. 6 manufacturers reported payments, led by Astrazeneca UK Limited at 57.7% of the total. Reporting peaked in 2023 at $56,058 and has fallen 79.6% since, to $11,422 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$177,348in general payments, 2019–2025

Across 116 payments — averaging $1528.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astrazeneca UK Limited$102K
  • AstraZeneca$51K
  • Astrazeneca AB$10K
  • Covidien LP$9K
  • Novartis$3K
  • Eli Lilly$2K
$34,073in research payments, 2019–2025

Across 1 payment — averaging $34,073 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Astrazeneca UK Limited$34K

What the payments were for

  • Consulting fees$112,19763%
  • Speaking & faculty fees$8,5005%
  • Travel & lodging$54,50631%
  • Food & beverage$2,1451%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Astrazeneca UK Limited60$102,265
AstraZeneca41$51,121
Astrazeneca AB8$9,904
Covidien LP3$9,356
Novartis3$2,902
Eli Lilly1$1,800

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$177,348 in reported general payments places this provider in the 95th percentile of 132 thoracic surgery (cardiothoracic vascular surgery) providers in North Carolina.

See all thoracic surgery (cardiothoracic vascular surgery) providers in North Carolina

Medicare billing

Part B allowed, 2024
$49,473
Medicare patients
88
Services billed
166

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →